Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial
René Adam(Inserm), M. Lewin(Université Paris-Saclay), Victoire Granger(Canadian Partnership Against Cancer), Petru Bucur(Université de Tours), Valério Lucidi(Université Libre de Bruxelles), David Badrudin(Université Paris-Saclay), Karen Geboes(Universitair Ziekenhuis Leuven), Umberto Cillo(University of Padua), Denis Pezet(Centre Hospitalier Universitaire de Clermont-Ferrand), Fabrice Muscari(Université de Lille), Heithem Jeddou(Institut de Recherche en Informatique et Systèmes Aléatoires), Maximiliano Gelli(Université Paris-Saclay), L. Chiche(Université de Bordeaux), Jean Hardwigsen(Cliniques Universitaires Saint-Luc), Emmanuel Boleslawski(Université de Lille), Jan Lerut(Ghent University Hospital), François Cauchy(University of Padua), Bruno Heyd(Centre Hospitalier Universitaire de Besançon), Mickaël Lesurtel(Université Paris Cité), Michel Ducreux(Université Paris-Saclay), Pietro Majno(Ospedale regionale di Lugano), Nadjia Boukhedouni(Assistance Publique – Hôpitaux de Paris), Lamiae Grimaldi(Université Paris-Saclay), Olivier Scatton(Assistance Publique – Hôpitaux de Paris), Jean‐Yves Mabrut(Université Claude Bernard Lyon 1), Francis Lévi(Université Paris-Saclay), Chris Verslype(Universitair Ziekenhuis Leuven), Laurent Coubeau(Cliniques Universitaires Saint-Luc), Céline Piedvache(Université Paris-Saclay)
Cited by 34
Related Papers
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
|Nature Biotechnology|2000|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k